References
- Ma S , ChenC , JiXet al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J. Hematol. Oncol.12(1), 121 (2019).
- Pan T . N6-methyl-adenosine modification in messenger and long non-coding RNA. Trend. Biochem. Sci.38(4), 204–209 (2013).
- Zhang C , FuJ , ZhouY. A review in research progress concerning m6A methylation and immunoregulation. Front. Immunol.10, 922 (2019).
- Sekar D , LakshmananG , ManiP , BirunthaM. Methylation-dependent circulating microRNA 510 in preeclampsia patients. Hypertens. Res.42(10), 1647–1648 (2019).
- Sekar D , JohnsonJ , BirunthaM , LakhmananG , GurunathanD , RossK. Biological and clinical relevance of microRNAs in mitochondrial diseases/dysfunctions. DNA Cell Biol. doi:10.1089/dna.2019.5013 (2019) ( Epub ahead of print).
- Zhang L , WuH , ZhaoM , ChangC , LuQ. Clinical significance of miRNAs in autoimmunity. J. Autoimmun.109, 102438 (2020).
- Alarcón CR , LeeH , GoodarziH , HalbergN , TavazoieSF. N6-methyladenosine marks primary microRNAs for processing. Nature519(7544), 482–485 (2015).
- Han J , WangJZ , YangXet al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol. Cancer18(1), 110 (2019).
- Chen T , HaoYJ , ZhangYet al. m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. Cell Stem Cell16(3), 289–301 (2015).
- Li LJ , FanYG , LengRX , PanHF , YeDQ. Potential link between m6 A modification and systemic lupus erythematosus. Mol. Immunol.93, 55–63 (2018).